What Researchers Did
Researchers conducted a review of scientific literature published between January 2019 and January 2020 to summarize recent findings on fibromyalgia diagnosis, causes, and treatment.
What They Found
The review highlighted the emerging concept of nociplastic pain in fibromyalgia, alongside identified neuroendocrine and metabolic alterations in patients. It also discussed novel applications of existing drugs and various complementary therapies, including hyperbaric oxygen chamber, ozone therapy, and mindfulness-based interventions.
What This Means for Canadian Patients
Canadian patients with fibromyalgia may benefit from a better understanding of their condition, including the role of nociplastic pain and potential underlying biological changes. This review suggests that a range of treatment options, from existing medications to complementary therapies like hyperbaric oxygen or mindfulness, could be considered to manage their symptoms.
Canadian Relevance
This review article does not have a direct Canadian connection, as it summarizes international research on fibromyalgia.
Study Limitations
As a review, this study's limitations include its reliance on previously published research and the potential for selection bias in the included literature.